MicroVention HydroCoil Cerebral Aneurysm Postmarket Study Set To Launch
This article was originally published in The Gray Sheet
Executive Summary
MicroVention will conduct a three-to-six month, 20-center study to support marketing for its HydroCoil embolic system, 510(k)-cleared July 29